Contact this trialFirst, we need to learn more about you.
Vitamin A Derivative
ALK-001 for Stargardt Disease
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial tests a modified vitamin A pill called ALK-001 for people with Stargardt disease. The drug aims to prevent harmful clumps of vitamin A in the eye that cause vision loss.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service